Slide 1: Exchange filing cover letter: Corporate Presentation
16.08.2023 To, National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, Floor- 25, P J Tower, Bandra-Kurla Complex, Dalal Street, Bandra (East) Mumbai 400 051 Mumbai 400 001 SYMBOL:- MFL Scrip Code 543332 Dear Sir, Sub.: Corporate Presentation Ref.: Regulation 30 of SEBI (LODR) Regulat
Slide 2: Epigral Limited Corporate Presentation
Epigral Limited (formerly known as Meghmani Finechem Ltd) Corporate Presentation
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Meghmani Finechem Limited (the “Company”) solely for the information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities and shall
Slide 4: Company Overview
Company Overview Founded: 2007 30% 22% 5 Year Revenue CAGR (FY23) 5 Year EBITDA CAGR (FY23) Employees: 900+ 0.8x 32% Debt to Equity (FY23) ROCE (FY23) Capacity: Chlor-Alkali# – 421 KTPA Derivatives# – 190 KTPA 5,000 Revenue from operations (₹ Cr) 2188 Certified: 1551 Responsible Care Certificate 710
Slide 5: Our Journey
Our Journey FY2023 FY2022 FY2021 Commissioned and increased FY2020 Listed as an capacity independent FY2017 Commissioned entity on 18th Epichlorohydrin and increased August 2021 – 50 KTPA FY2015 Commissioned capacity Announced CPVC Resin – FY2010 Commissioned CMS - 50 Caustic Soda - expansion in 30
Slide 6: Rebranding
Rebranding is now • Renaming is undertaken to strengthen the corporate brand in line with the company’s commitment to transform the company as a global multi-product chemical conglomerate and enhance our reputation as an integral partner for esteemed clients and our stakeholders • This is done throu
Slide 7: Diversified and integrated portfolio
Diversified and integrated portfolio Fully Integrated Product Portfolio CPVC High Value Products Import Substitution – Make in India H2O2 ECH Chlor- Alkali Diversified End User Industries Chlorotoluene Sole Manufacturer of ECH in India CMS & value chain Diversifying Portfolio; De-Risking Business Mo
Slide 8: Fully Integrated Complex
EPIGRAL Fully Integrated Complex [cot rr =a a Caustic Soda Lye 32% gl Caustic Soda Flakes Sodium Chloride > | Caustic Soda (400 KTA) kK Ha ——— pk a Sodium Hypochlorite in Caustic Potash Lye = H2 Caustic Potash Flakes Ba bed l Chloromethanes (50 KTA) j Methyl Chloride Chlorine Gas Pipeline Sulfuric A
Slide 9: Our Values
Our Values Together, in caring and agile manner, we make it happen
Slide 10: Competitive Strength
Competitive Strength Well Invested Infrastructure Well established brand o State of the art manufacturing facility o Epigral is a known brand in Indian chemical market o Strategic location with close connectivity to ports o Serving domestic customers for last 12 Yrs and raw material availability. o
Slide 11: Catering to high growth industries
Catering to high growth industries Increased market potential & higher growth exposure Refinery Paper & Pulp Fluoropolymers Soap & Detergents Textiles Dyes & Pigment Pharmaceuticals Agrochemicals Alumina PU Foams Paints PTFE Pipes CPVC Pipes Refrigerant Gas Water Treatment Electronics The addressabl
Slide 12: Capacities
Capacities Manufacturing Plant Capacity (KTPA) 400 Q4FY24 Q4FY24 45 60 50 50 30 21 CPVC Resin Epichlorohydrin Chloromethanes Hydrogen Peroxide Chlorotoluene & its Caustic Soda Caustic Potash *Q2FY23 *Q1FY23 *Q2FY20 *Q2FY21 value chain Expected Commissioning, * Commissioning date
Slide 13: Transitioning towards Derivatives & Specialty Chemicals
Transitioning towards Derivatives & Specialty Chemicals 30% <40% FY2023 FY2027(E) Derivatives ₹2,188 Cr 26% ₹5,000 Cr >60% 70% Derivatives & Specialty Chlor-Alkali Derivatives & Specialty Chlor-Alkali Revenue from the derivatives and specialty segment to be >60% by FY27E Derivatives & Specialty – CP
Slide 14: Chlor-Alkali
Chlor-Alkali Caustic Soda (NaOH) Caustic Potash (KOH) India’s NaOH Requirement: ~ 4,500 KTPA India’s KOH Requirement: 94 KTPA Demand CAGR: ~ 8% Demand CAGR: ~ 8% Alumina Textile Chemicals Agrochemicals API o We are 4th largest producer in India o We are 3rd largest producer in India o Causti
Slide 15: Derivative Products
Derivative Products Chloromethanes (CMS) Hydrogen Peroxide (H2O2) India’s CMS Requirement: 580 KTPA India’s H2O2 Requirement: 340 KTPA Demand CAGR: ~ 12% Demand CAGR: ~ 10% Solvent in Pharma PTFE Pipes Refrigerant Gas Paper & pulp Textile Chemicals o We are 5th largest producer in India o We
Slide 16: Derivatives & Specialty Chemicals
Derivatives & Specialty Chemicals CPVC Resin Epichlorohydrin (ECH) India’s CPVC Requirement: 200 KTPA India’s ECH Requirement: 85 KTPA Demand CAGR: ~ 13% Demand CAGR: ~ 15% Wind mill Automobile Adhesives Pipes and Fixtures o Largest producer in India o 1st company in India to produce sustain
Slide 17: Chlorotoluene & Value Chain
Chlorotoluene & Value Chain Project Details Rationale o Capex for the project will be ₹ 180 Cr and expected o Foundation for the next phase of growth in Specialty revenue of Rs. 300 Cr Chemicals o Expected commissioning date: Q4FY24 o Chlorine is captive a raw material - in line to strengthen fully
Slide 18: Research & Development Centre
Research & Development Centre Project Details Rationale o Capex for the project will be ₹ 25 Cr o R&D center will be used for creating further molecules for Chlorotoluene and other new molecules, which will be intermediates for pharmaceutical and agrochemical o A step towards strengthening presence
Slide 19: Focused on ESG
Focused on ESG ENVIRONMENT o Focused on using best technology to manage critical resources, to moderate the consumption of energy and natural resources and drive operations efficiently o Focus is to manufacture more from less, basis for environment responsibility o Entered in JV to set up 18.34 MW W
Slide 20: Growth Strategy
Growth Strategy Forward & Backward Opportunities in high New Value Chains: Achieving economies Integration: growth sectors: of scale: o Scale up capacities in o Explore opportunities o Expand chemistry o Optimising existing existing products in various sectors expertise to enter complex o New value
Slide 21: Financial Performance – P&L
Financial Performance – P&L Revenue from operations (₹ Cr) EBIDTA (₹ Cr and %) PAT (₹ Cr and %) 2,188 44% 25% 33% 1,551 32% 31% 32% 689 18% 16% 16% 509 829 12% 353 710 611 312 253 261 194 183 112 101 FY2019 FY2020 FY2021 FY2022 FY2021 FY2019 FY2020 FY2021 FY2022 FY2023 FY2019 FY2020 FY2021 FY2022 FY
Slide 22: Balance Sheet Ratios
Balance Sheet Ratios ROCE (%) ROE (%) Net Debt/EBITDA (x) 39% 36% 36% 36% 32% 29% 2.7 21% 2.1 1.9 16% 16% 15% 1.3 1.3 FY2019 FY2020 FY2021 FY2022 FY2021 FY2019 FY2020 FY2021 FY2022 FY2023 FY2019 FY2020 FY2021 FY2022 FY2023
Slide 23: Historic Income Statement
Historic Income Statement Particulars (₹ Cr) FY19 FY20 FY21 FY22 FY23 Total Revenue 720 613 831 1,555 2,196 Gross Profit* 431 300 407 716 951 Gross Margin (%) 61% 49% 49% 46% 43% EBITDA 312 194 261 509 689 EBITDA Margin (%) 44% 32% 32% 33% 31% Depreciation 54 44 74 86 109 Finance Cost 25 11 29 44 66
Slide 24: Historic Balance Sheet
Historic Balance Sheet Assets (₹ Cr) FY21 FY22 FY23 Liabilities (₹ Cr) FY21 FY22 FY23 Fixed Assets 1,228 1,657 1,962 Share Capital 42 42 42 Financial Assets 10 8 28 Reserves & Surplus 643 684 1,028 Other Non-current Assets 29 11 23 Long-Term Borrowings 340 557 396 Inventories 54 154 212 Redeemable P
Slide 25: About us and Investor Contact
About us and Investor Contact Epigral Ltd (formerly known as Meghmani Finechem Ltd), For further information incorporated in 2007, is a leading integrated manufacturer of chemicals in India. The company has state of the art Please log on to website - manufacturing facilities in Gujarat, Dahej – a le